Moderna | MRNA - Sales Revenues

Stock Price
41.01
Daily Change
0.14 0.34%
Monthly
14.27%
Yearly
25.80%
Q1 Forecast
42.71

Moderna reported $1.02B in Sales Revenues for its fiscal quarter ending in September of 2025.





Sales Change Date
Acadia Pharmaceuticals USD 278.6M 14M Sep/2025
Agios Pharmaceuticals USD 12.9M 450K Sep/2025
Alnylam Pharmaceuticals USD 1.25B 476.31M Sep/2025
Amgen USD 9.9B 340M Dec/2025
Arrowhead Research USD 264.03M 7.56M Dec/2025
Biogen USD 2.28B 250M Dec/2025
BioMarin Pharmaceutical USD 776M 49M Sep/2025
Celltrion KRW 1.03T 68.49B Sep/2025
Cspc Pharmaceutical CNY 6.62B 358.95M Sep/2025
Dianthus Therapeutics USD 396K 203K Sep/2025
Divis Laboratories Ltd INR 27.15B 3.05B Sep/2025
Gilead Sciences USD 7.8B 700M Sep/2025
GlaxoSmithKline GBP 8.62B 73M Dec/2025
Incyte USD 1.37B 310M Sep/2025
Ionis Pharmaceuticals USD 157M 295M Sep/2025
Kangmei Pharma CNY 1.37B 101.16M Sep/2025
Knight Therapeutics CAD 92.26M 3.31M Sep/2024
Laboratorios Farma EUR 448.66M 67.82M Dec/2023
Moderna USD 1.02B 878M Sep/2025
Organigram Holdings CAD 80.06M 9.27M Sep/2025
Pharma Mar EUR 35.7M 20.69M Sep/2025
Qiagen NV USD 457.38M 6.06M Dec/2025
Regeneron Pharmaceuticals USD 3.88B 130M Dec/2025
Sarepta Therapeutics USD 399.4M 211.69M Sep/2025
Sartorius EUR 927.6M 84.4M Dec/2025
Sino Biopharmaceutical CNY 17.57B 4.58B Jun/2025
Tilray USD 217.51M 74.75M Dec/2025
Ultragenyx Pharmaceutical USD 160M 6.5M Sep/2025
United Therapeutics USD 799.5M 900K Sep/2025
Vertex Pharmaceuticals USD 3.08B 120M Sep/2025
Zhangzhou Pientzehuang Pharmaceutical CNY 2.88B 642.99M Sep/2025